Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-11

FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals to market a generic finasteride product, expanding access to the reference indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)

Snippet

SUPPL AP for FINASTERIDE (FINASTERIDE)